This Startup Is Developing Finger-Prick Blood Tests, But Don ' t Call It Theranos 2

Sight Diagnostics believes it can succeed where Theranos failed, developing rapid finger-prick blood tests, but its approach is nothing like that of the failed Silicon Valley startup chronicled in the bestselling book Bad Blood.

Source: Forbes.com Healthcare News - July 13, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news